The Scope of Things
The Scope of Things
Episode: 22 - Clinical News, Start-Ups, and More With Ward Lemaire and Dan Hydes
New Year, new podcast format! In 2024’s first episode of the Scope of Things, host Deborah Borfitz gives you the latest news from the clinical trials industry, including AI’s role in the creation of digital twins, the obesity epidemic and the drugs intended to combat it, improving diversity in trial candidates, and more. We also have expert advice from Ward Lemaire, VP Head of Data Management and Central Monitoring at J&J Innovative Medicine, and Dan Hydes, Co-Founder and CEO at IgniteData, on SCOPE’s new Startup Pitch Competiton, and how start-up companies can meet multiple demands and needs, direct their limited resources, and keep the innovation train going.
New Advisory Board
News Roundup
AI and Chatbots
- Belong.Life
- Microsoft’s Trial Matcher
- UF and NVIDIA’s GatorTronGPT
- Genentech’s smart digital assistants
Digital Twins
Obesity Clinical Trials
- JAMA paper on unintended consequences of weight-loss drugs
- FDA’s Ozempic label change
- Physicians in Europe preferentially recommend lifestyle changes
New areas of interest
- Trial begins for Insilico Medicine’s latest AI-discovered drug
- Brain metastases studies in Italy and Spain
- Drug repurposing study in Australia for type 1 diabetes
- Anti-aging TAME trial of Metformin to start
Pharmacy Research Organization RxE2
The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.